ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALGW Alpha Growth Plc

2.05
0.15 (7.89%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alpha Growth Plc LSE:ALGW London Ordinary Share GB00BYWKBC49 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 7.89% 2.05 1.90 2.20 2.05 1.90 1.90 5,195,074 08:01:39
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Management Consulting Svcs 7.88M 3.18M 0.0068 3.01 9.59M
Alpha Growth Plc is listed in the Management Consulting Svcs sector of the London Stock Exchange with ticker ALGW. The last closing price for Alpha Growth was 1.90p. Over the last year, Alpha Growth shares have traded in a share price range of 1.05p to 2.35p.

Alpha Growth currently has 467,775,068 shares in issue. The market capitalisation of Alpha Growth is £9.59 million. Alpha Growth has a price to earnings ratio (PE ratio) of 3.01.

Alpha Growth Share Discussion Threads

Showing 951 to 973 of 9575 messages
Chat Pages: Latest  47  46  45  44  43  42  41  40  39  38  37  36  Older
DateSubjectAuthorDiscuss
17/10/2018
14:52
North London Jewish mafia money coming in been told should get Interesting now
toolsmoker
17/10/2018
13:46
Rumours of even bigger ticket that's why the delay .let's be having it Mr swick
toolsmoker
17/10/2018
11:58
All stock cleared under 3p
fishybits
17/10/2018
11:49
What's 'appnin!!!!!!!!
2acorn
17/10/2018
10:18
Looks like it’s all sausage and no sizzle !
hungary16
16/10/2018
17:37
What I should of said was no contracts since the ramp brigade arrived. They keep saying contracts imminent and surprisingly nothing happens.
richardjohn10
16/10/2018
17:35
First contract was announced on 21/12/17.We await the first under Danny Swick.
mac_steven
16/10/2018
17:26
Still no deals made, the share price will fall back to placing soon.Hopefully anyway as I want to top up
richardjohn10
16/10/2018
16:12
No so nice when someone's doing to a share your actually invested in.....
k19ten
16/10/2018
15:35
moved up on no buys!
reks
16/10/2018
15:07
Frustrating as i thought the churn was done with a while back
reks
16/10/2018
15:03
Still plenty of people dumping below 2.40p... sigh...
cyberbub
16/10/2018
15:02
News coming according to Bluehorse on twitter
reks
16/10/2018
14:56
full ask paid yet they won't move it up....cant buy many without NT
reks
16/10/2018
14:20
All this needs is a couple of decent buys and the mm’s will be crying out for stock. A large order is still being filled. Buy and hold!!!
cudmore
16/10/2018
11:35
Hopefully see a bit of blue soon as today would be 4 red days in succession which rarely happens
reks
16/10/2018
10:05
There are a large range of services Alpha are offering to clients not just administration fees on magaing the portfolio of SLS policies:

The Company expects to acquire and retain clients which are institutions through existing relationships of the
Directors and by active promotion within the SLS Asset sector.
The Company expects these clients to require the following range of services:
Advisory

• Advice on existing SLS portfolios to achieve target returns including diversification of portfolios by way of underlying medical conditions, gender and carriers

• Due diligence including a review of exclusions, riders, maturity dates and credit ratings
• The servicing of acquired policies
• The valuation and modelling of the SLS Assets
• Reporting and monitoring of the deaths of the underlying Insured
• Communication with underwriting insurance companies
• Fund collections on maturity
• Reporting and monitoring on the performance of the insurance companies which have written Policies
contained in client portfolios
• Regulation, risk and litigation analysis
• Review of Valuation Basic Table changes which impact on portfolio analysis
• The project management of specific opportunities within the SLS Asset class
Acquisition
• The sourcing of SLS Assets
• Aggregation of SLS Assets for larger mandated orders with minimum transaction sizes
• Initial analysis to establish price
• Advice on the execution of SLS Asset portfolio acquisitions including title transfers
• Structuring of acquisition vehicles
Disposal
• The analysis of pricing policies in relation to potential disposals or part-disposals
• Advice on potential portfolio buyers
• Advice on the execution of portfolio disposals

euclid5
16/10/2018
10:00
wonder who is under Pershing Nominees at Algw - have a huge sholder interest

Pershing Nominees s/holding: 21,465,000 = 42.86%

euclid5
16/10/2018
09:57
your wellcome, they are a closed-ended investment company.

Yes more capital intensive, when Algw just act as a manager for these type of co's & collect their admin fees

Yes, Acheron Capital Limited is the invst manager for their funds - they have a good team profile:



Listed in March 2018, so after Algw - worth watching how they perform

euclid5
16/10/2018
08:44
Thank you Euclid
alexios1201
15/10/2018
21:34
Interestingly there's a mention of "Acheron Capital", who are more like ALGW perhaps, ie. providing professional advice to the actual SLS investors?
cyberbub
15/10/2018
21:32
Euclid, I didn't realise that LSA actually owned the policies - so yes, a different business model to ALGW. But still the same industry anyway.ALGW is less risky and capital-intensive, but with lower profits. Suits me, especially with a market cap below £3M, only £1M annual outgoings, high margin revenues, and potential revenues of several million quid a year (*if* Swick delivers on his promises...)NAI
cyberbub
15/10/2018
21:10
The life settlement industry in the United States during the first six months of 2018 was marked by the Tax Cuts and Jobs Act 2017 (TCJA). This is a boost to the market as it brings feasibility to policyholders to sell their policy. Previously, tax basis calculation for people selling their insurance policies and those surrendering was different: the former could deduct from sales proceeds past cumulative Cost of Insurance (COI), while the latter imputed past cumulative premium payments.

Because information on past COI was difficult and sometimes impossible to obtain, many people lapsed or surrendered a policy. TCJA makes the basis calculation for both approaches identical, resulting in the abolition of a tax incentive to surrender rather than to sell a policy. This measure will support the supply of life settlements. Meanwhile, efforts have been made to streamline the policy selling process with the help of electronic health records and short-form underwriting. These approaches have the potential to transact a much larger number of policies in a shorter time and thus make transactions more accessible for millions of people.

euclid5
Chat Pages: Latest  47  46  45  44  43  42  41  40  39  38  37  36  Older